NeurologyLive® Mind Moments®

138 Odcinki

1. 107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers

   Opublikowany: 26.01.2024
2. 106: Potential Role of Stathmin-2 in Amyotrophic Lateral Sclerosis

   Opublikowany: 12.01.2024
3. 105: Recapping Conversations in Neurology From 2023

   Opublikowany: 29.12.2023
4. 104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2

   Opublikowany: 15.12.2023
5. 103: Advancing Epilepsy Care and Seizure Localization in Pediatrics

   Opublikowany: 1.12.2023
6. 102: Potential of Gamma Sensory Stimulation in Alzheimer Disease

   Opublikowany: 17.11.2023
7. Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular Dystrophy

   Opublikowany: 7.11.2023
8. 101: Ways to Enhance Neuromodulation in Parkinsonism

   Opublikowany: 3.11.2023
9. Special Episode: FDA Approves Zilucoplan for Myasthenia Gravis

   Opublikowany: 23.10.2023
10. 100: 2023 ECTRIMS-ACTRIMS Meeting Highlights

    Opublikowany: 20.10.2023
11. 99: Understanding AMX0035's Potential in Progressive Supranuclear Palsy

    Opublikowany: 5.10.2023
12. 98: Uncovering Phenotypical Features of Narcolepsy Type 1

    Opublikowany: 22.09.2023
13. 97: Identifying Gaps in Access to Parkinson Disease Care

    Opublikowany: 8.09.2023
14. 96: Complexities With Cognitive Screening in Primary Care Settings

    Opublikowany: 25.08.2023
15. Special Episode: Addition of Valbenazine to Treat Huntington Disease Chorea

    Opublikowany: 21.08.2023
16. 95: Expanding Potential for Long-Term Treatment in SMA

    Opublikowany: 11.08.2023
17. 94: The Discussion Surrounding Lecanemab's Approval for Alzheimer Disease

    Opublikowany: 28.07.2023
18. 93: Caring for Women With Parkinson Disease

    Opublikowany: 14.07.2023
19. 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings

    Opublikowany: 30.06.2023
20. Special Episode: SRP-9001 Approved As First Gene Therapy for Duchenne Muscular Dystrophy

    Opublikowany: 22.06.2023